|
Originally published In Press as doi:10.1074/jbc.M002950200 on June 28, 2000
J. Biol. Chem., Vol. 275, Issue 36, 27838-27844, September 8, 2000
Ouabain Interaction with Cardiac
Na+/K+-ATPase Initiates Signal Cascades
Independent of Changes in Intracellular Na+ and
Ca2+ Concentrations*
Jiang
Liu ,
Jiang
Tian ,
Michael
Haas ,
Joseph I.
Shapiro§,
Amir
Askari , and
Zijian
Xie ¶
From the Departments of Pharmacology and
§ Medicine, Medical College of Ohio, Toledo, Ohio
43614
Received for publication, April 7, 2000, and in revised form, June 22, 2000
 |
ABSTRACT |
We have shown previously that partial inhibition
of the cardiac myocyte Na+/K+-ATPase
activates signal pathways that regulate myocyte growth and
growth-related genes and that increases in intracellular
Ca2+ concentration ([Ca2+]i) and
reactive oxygen species (ROS) are two essential second messengers
within these pathways. The aim of this work was to explore the relation
between [Ca2+]i and ROS. When myocytes were in a
Ca2+-free medium, ouabain caused no change in
[Ca2+]i, but it increased ROS as it did when the
cells were in a Ca2+-containing medium. Ouabain-induced
increase in ROS also occurred under conditions where there was little
or no change in [Na+]i. Exposure of myocytes in
Ca2+-free medium to monensin did not increase ROS. Increase
in protein tyrosine phosphorylation, an early event induced by ouabain,
was also independent of changes in [Ca2+]i and
[Na+]i. Ouabain-induced generation of ROS in
myocytes was antagonized by genistein, a dominant negative Ras, and
myxothiazol/diphenyleneiodonium, indicating a mitochondrial origin for
the Ras-dependent ROS generation. These findings, along
with our previous data, indicate that increases in
[Ca2+]i and ROS in cardiac myocytes are induced
by two parallel pathways initiated at the plasma membrane: One being
the ouabain-altered transient interactions of a fraction of the
Na+/K+-ATPase with neighboring proteins (Src,
growth factor receptors, adaptor proteins, and Ras) leading to ROS
generation, and the other, inhibition of the transport function of
another fraction of the Na+/K+-ATPase leading
to rise in [Ca2+]i. Evidently, the gene
regulatory effects of ouabain in cardiac myocytes require the
downstream collaborations of ROS and
[Ca2+]i.
 |
INTRODUCTION |
Ouabain and related cardiac glycosides are specific inhibitors of
Na+/K+-ATPase, the enzyme that carries out the
active transport of Na+ and K+ across the
plasma membrane of most animal cells (1, 2). In the heart, interaction
of cardiac glycoside drugs with the Na+/K+-ATPase regulates contractility. It is
now widely accepted that partial inhibition of the cardiac myocyte
Na+/K+-ATPase by a cardiac glycoside causes a
modest increase in
[Na+]i,1
which in turn affects the plasma membrane
Na+/Ca2+-exchanger, leading to a significant
increase in [Ca2+]i and in the force of
contraction (3-5). This positive inotropic effect of cardiac
glycosides is the basis of the major therapeutic use of these drugs in
the management of congestive heart failure (3-6).
The cumulative findings of our laboratories during the past few years
(7-12) have revealed the following previously unknown effects of
ouabain on cardiac myocytes: 1) The same nontoxic concentrations of
ouabain that cause partial inhibition of
Na+/K+-ATPase and increase in
[Ca2+]i also stimulate the nonproliferative
growth (hypertrophy) of the myocytes and regulate the transcription of
a number of growth-related genes. 2) These ouabain effects involve the
activation of multiple signal transduction pathways, including the
activation of Src kinase and tyrosine phosphorylation of the epidermal
growth factor receptor and other proteins, followed by the activation of Ras and the Ras/Raf/MEK/MAPK cascade. 3) The gene regulatory actions
of ouabain, like its classical effect on cardiac contractility, are
dependent on the net influx of Ca2+ and rise in
[Ca2+]i, indicating that the latter is a shared
second messenger for the ouabain effects on cardiac contractility and
growth. 4) Ouabain's hypertrophic and gene regulatory effects also
involve intracellularly generated ROS as essential second messengers. Significantly, our studies also showed (11) that antioxidants block the
ouabain-induced ROS generation but not the ouabain-induced inhibition
of the Na+/K+-ATPase and increase in
[Ca2+]i, raising important questions regarding
the relationship between the two essential second messengers of ouabain
interaction with the cardiac Na+/K+-ATPase. For
the clarification of the mechanism of the signal transducing function
of the Na+/K+-ATPase, it seemed necessary to
determine if the two second messengers, [Ca2+]i
and ROS, are generated sequentially or in parallel, and the order of
their generations. The primary aim of the studies reported here was the
resolution of these and related issues. A preliminary account of
portions of this work has been presented (13).
 |
EXPERIMENTAL PROCEDURES |
Cell Preparation and Culture--
The same protocol was used to
prepare and culture neonatal ventricular myocytes as described in our
previous work (7). In short, myocytes from 1-day-old Harlan
Sprague-Dawley rats were isolated and purified on Percoll gradients. In
a medium containing four parts of DMEM and one part Medium 199 (Life
Technologies, Inc.), penicillin (100 units/ml), streptomycin (100 µg/ml), and 10% fetal bovine serum, myocytes were cultured for
24 h at 37 °C in humidified air with 5% CO2. After
24 h, the myocytes were serum-starved for 48 h at which time
all experiments were performed. Some of the experiments were done in a
nominally Ca2+-free medium, which was prepared to contain
the same components as DMEM except that calcium salts were omitted and
0.1 mM EGTA was added to the medium. As we previously
reported, incubation of cardiac myocytes in this medium had no
significant effect on cell viability for the experimental durations
used here (7). Immunofluorescence staining with a myosin heavy chain
antibody showed that the cultures contained more than 95% myocytes.
Fluorescence Microscopic Measurements of
[Ca2+]i, [Na+]i, and
ROS--
Myocytes were cultured on glass coverslips.
[Ca2+]i was measured by fura-2 as we previously
described (7, 11). The fura-2 fluorescence was recorded using an
Attofluor imaging system (Atto Instruments) at an excitation wavelength
of 340/380 nm and at an emission wavelength of 505 nm. Under each
experimental condition time-averaged signals were obtained from about
40 single cells. [Ca2+]i was calculated based on
the fluorescence ratio and the Ca2+calibration curve (7,
11). To measure [Ca2+]i transients, myocytes were
loaded with 10 µM indo-1-AM for 30 min. Indo-1
fluorescence was recorded using a microscope-based fluorescence system
(Photon Technology International, Monmouth Junction, NJ). The probe was
excited at 365 nm, and fluorescence emitted at 405 and 485 nm was
recorded. The emission ratio was recorded at a speed of 60 Hz.
[Na+]i was determined by the fluorescent probe
SBFI. Myocytes were loaded with 5 µM SBFI-AM and 0.075%
Pluronic, a surfactant, for 30 min at 37 °C and washed. SBFI
fluorescence was recorded as in the case of the fura-2 signal at an
excitation wavelength of 340/380 nm and at an emission wavelength of
505 nm. Calibration of [Na+]i was done by
modifications of established procedures (14, 15). Briefly, SBFI-loaded
myocytes were incubated in a solution containing 10 µM
monensin, a Na+-specific ionophore. Calibration solutions
contained 0-80 mM Na+.
[Na+]i in control and treated myocytes was then
calculated based on this calibration curve. Substitution of 10 µM gramicidin for monensin caused no significant change
in the calibration curve within the range of 0-80 mM
Na+. Intracellular ROS production in cells loaded with 10 µM CM-DCFH diacetate for 15 min at room temperature in
the dark was measured as we previously described (11). Under each
experimental condition, about 15 single myocytes were imaged with an
Attofluor imaging system, and CM-DCF fluorescence was measured at an
excitation wavelength of 480 nm and an emission wavelength of 520 nm.
All the chemicals for these fluorescence assays were obtained from Molecular Probes (Eugene, OR).
Measurement of Tyrosine Phosphorylation--
Immunoblotting,
using an anti-phosphotyrosine antibody with established specificity
(PY99, Santa Cruz Biotechnology, Santa Cruz, CA), was performed as we
described previously (12). The quantitative comparisons of the
intensities of the bands were also done as described previously
(12).
Preparation of Replication-defective Adenovirus Asn17
Ras and Adenovirus Infection of Cardiac Myocytes--
A
replication-defective adenovirus expressing the dominant negative
Asn17 Ras was generated, amplified, purified, and used for
the infection of myocytes as we described previously (10). An identical
virus containing the -galactosidase gene instead of the
Asn17 Ras was used as the control (10).
 |
RESULTS |
Effects of Ouabain on ROS and [Ca2+]i in
Cardiac Myocytes--
Our previous data (11) on the differential
effects of an antioxidant on the ouabain-induced increases in
[Ca2+]i and ROS suggested that either the
ouabain-induced ROS generation occurred within a pathway parallel to
that causing the rise in [Ca2+]i, or that the
increased [Ca2+]i led to ROS generation, but that
the antioxidant effect was distal to the rise in
[Ca2+]i. To test these alternatives, ouabain
effects on intracellular ROS generation were compared in myocytes
incubated in the normal Ca2+-containing culture medium and
those incubated in a Ca2+-free culture medium. The
ouabain-induced ROS generation was nearly identical under the two
conditions (Fig. 1). Because it is based on the accepted mechanism of ouabain action in cardiac myocytes (3-5),
ouabain is not expected to increase [Ca2+]i when
myocytes are in a Ca2+-free medium; therefore, the data in
Fig. 1 suggest that ROS generation is independent from increased
[Ca2+]i. To see if this could be firmly
established, we examined the effects of ouabain on
[Ca2+]i and on the spontaneous contractions of
the myocytes exposed to the Ca2+-containing and the
Ca2+-free media. As noted previously (7, 16, 17), the
neonatal rat cardiac myocytes that are cultured at relatively low
densities and serum-starved ("Experimental Procedures") are
predominantly quiescent; i.e. most do not contract
spontaneously, and some contract with a low rate. When these myocytes,
in a normal Ca2+-containing medium, were exposed to 100 µM ouabain, both the number of contracting cells and the
rate of contractions increased. This is depicted in Fig.
2 where contractions in a population of
cells, observed under a microscope, were counted before and after the addition of ouabain. The ouabain-induced increase in the rate of
contraction was also observed when [Ca2+]i
transients, each representing a contraction, were monitored with indo-1
in single myocytes that were in the normal Ca2+-containing
medium, as shown in Fig. 3A
for a representative single cell. Ouabain-induced increase in
[Ca2+]i was also evident in single cells (Fig.
3A), where diastolic [Ca2+]i started
to rise 2-3 min after exposure to ouabain. The time-averaged mean of
[Ca2+]i in cell populations, placed in the
Ca2+-containing medium and assayed after 20 min, nearly
doubled in response to 100 µM ouabain as shown in Table
I.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
Effects of ouabain and monensin on
intracellular ROS production by myocytes incubated in
Ca2+-containing (control) and Ca2+-free
media. Myocytes loaded with CM-DCFH were incubated in the
indicated media for 15 min, exposed to 100 µM ouabain or
25 µM monensin, and then measured for CM-DCF fluorescence
as described under "Experimental Procedures." Each value is the
mean ± S.E. of determinations on 40-60 cells in three to five
independent experiments.
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of ouabain on myocyte contractile
activity in Ca2+-containing (control) and
Ca2+-free media. Myocytes were incubated in the
indicated media for 15 min then exposed to 100 µM ouabain
for various times. Five myocytes per dish were randomly chosen, and
spontaneous beating was counted under microscope for 30 s at each
time point. A total of 15 cells from three dishes were counted in each
experiment. Each value is the mean ± S.E. of determinations of 45 cells from three independent experiments. Myocytes exhibited no
spontaneous beating when incubated in the Ca2+-free DMEM
(data not shown).
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of ouabain on
[Ca2+]i transients in myocytes. Cells loaded
with indo-1 were incubated in either the Ca2+-containing
(A) or the Ca2+-free (B) medium for
15 min, exposed to 100 µM ouabain as indicated, and
measured for transients as described under "Experimental
Procedures." Each panel is a single cell tracing representative of
those noted in four independent experiments.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Different effects of 100 µM ouabain on
[Ca2+]i in rat neonatal cardiac myocytes incubated in
Ca2+-containing and Ca2+-free media
Cells were loaded with fura-2, placed either in the normal
Ca2+-containing medium or the Ca2+-free medium for 15 min, exposed to ouabain, and monitored for changes in the fluorescence
signals as indicated under "Experimental Procedures." The
time-averaged mean of [Ca2+]i in cell populations
were determined 15-20 min after exposure to ouabain when
[Ca2+]i had stabilized.
|
|
When myocytes were placed in the Ca2+-free medium and
monitored for beating, no contractions were noted either before or
after the addition of ouabain (Fig. 2). This was also the case if the cells containing indo-1 were examined for [Ca2+]i
transients, as exemplified by the single cell tracing of Fig.
3B, where no increase in [Ca2+]i and
no transients were noted after ouabain addition. When
[Ca2+]i was measured in a population of myocytes
placed in the Ca2+-free medium, ouabain did not cause a
change in [Ca2+]i in sharp contrast to the
ouabain-induced doubling of the [Ca2+]i in
myocytes placed in the Ca2+-containing medium (Table I).
The above data, taken together, clearly indicate that in the cultured
cardiac myocytes used here ROS generation induced by 100 µM ouabain occurs independent of the ouabain-induced
increase in [Ca2+]i and the associated myocyte contraction.
Lack of Relation of the [Na+]i to the
Ouabain-induced ROS Generation in Myocytes--
Based on the
established reserve capacity of Na+/K+-ATPase
in various intact heart preparations and in chick cardiac myocytes (4,
5, 18, 19), the partial inhibition of
Na+/K+-ATPase caused by the highest ouabain
concentration (100 µM) used in the present studies was
expected to lead to either no increase or a modest increase in
[Na+]i of these myocytes (see "Discussion").
To see if this were indeed the case, we determined the effects of 100 µM ouabain on [Na+]i when myocytes
were incubated either in the Ca2+-containing medium or in
the Ca2+-free medium (Fig.
4). As expected from previous studies on
cardiac myocytes and isolated cardiac muscle preparations (20-22),
exposure of the cells to the Ca2+-free medium caused a
small increase in [Na+]i prior to the addition of
ouabain (Fig. 4). After the addition of ouabain, there were no
significant changes in [Na+]i during 30 min of
incubation in the Ca2+-containing medium, and only at one
time point (30 min) a small but significant increase in
[Na+]i of the cells incubated in the
Ca2+-free medium was noted (Fig. 4). These findings are
consistent with the degree of inhibition of
Na+/K+-ATPase of these myocytes by 100 µM ouabain (see "Discussion"). Clearly, comparison of
the data in Figs. 1 and 4 argues against the possibility of a
ouabain-induced rise in [Na+]i being responsible
for the increased ROS generation. To see if a large increase in
[Na+]i affects ROS generation, cells incubated in
the Ca2+-free culture medium containing 150 mM
Na+ were exposed to monensin, a Na+-specific
ionophore. Monensin did not increase ROS generation (Fig. 1). This
finding and the data of Fig. 4 rule out increased [Na+]i as a second messenger for the
ouabain-induced ROS generation in these myocytes when ouabain
concentration is 100 µM or less.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of the effects of 100 µM ouabain on
[Na+]i in cardiac myocytes. Cells loaded
with BSFI were incubated in the Ca2+-containing (control)
or the Ca2+-free medium for 15 min then exposed to ouabain
for various times. [Na+]i was measured as
described under "Experimental Procedures." Each value is the
mean ± S.E. of determinations from 30 different cells in three
independent experiments. *p < 0.05, relative to zero
time value in Ca2+-free medium. At each time point the
value for Ca2+-free medium was significantly larger than
the value in the corresponding control (p < 0.05).
|
|
Ouabain-induced Protein Tyrosine Phosphorylation in Myocytes
Incubated in a Ca2+-free Medium--
We have shown that in
neonatal cardiac myocytes ouabain, added to the normal
Ca2+-containing culture medium, causes a rapid increase in
protein tyrosine phosphorylation (12). When myocytes were placed in the
Ca2+-free medium, ouabain also induced rapid increases in
tyrosine phosphorylation of a number of proteins (Fig.
5). This result, and the data of Table I
and Figs. 3B and 4, clearly indicate that stimulation of
tyrosine phosphorylation by 100 µM ouabain is also not
due to changes in [Ca2+]i or
[Na+]i. Although the prominent
tyrosine-phosphorylated bands of Fig. 5 seem to be similar to those
noted in experiments done in the Ca2+-containing medium
(Figs. 2-5 of Ref. 12) and because we have not done a thorough
comparison of the phosphorylation patterns obtained in the
Ca2+-containing and Ca2+-free media, the
possibility of the existence of subtle but significant differences in
these patterns cannot be ruled out and remains to be explored.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
Time-dependent effects of
100 µM ouabain on tyrosine
phosphorylation of several proteins of myocytes incubated in the
Ca2+-free medium. Myocytes cultured in the normal
medium were incubated in the Ca2+-free medium for 15 min
before being exposed to ouabain for the indicated durations. Cell
lysates were prepared, and 60 µg of protein/lane was subjected to
SDS-polyacrylamide gel electrophoresis and immunoblotted with a
monoclonal anti-phosphotyrosine antibody as described under
"Experimental Procedures" and elsewhere (12). Quantitative
comparisons of the intensities of three prominent bands, with the
indicated apparent kDa values, were also done as previously described
(12), using appropriate exposure times for the different bands. The
indicated values are mean ± S.E. of four independent experiments.
The inset is a representative blot of three prominent
tyrosine-phosphorylated bands.
|
|
Relation of the Ouabain-induced ROS Generation in Myocytes to
Protein Tyrosine Phosphorylation and Ras--
Because the
ouabain-induced increases in tyrosine phosphorylation and ROS
generation were both found to be independent of increases in
[Ca2+]i and [Na+]i, we
explored the relation of the two ouabain-induced events. Genistein
blocked the ouabain-induced ROS production (Fig. 6), suggesting that increased protein
tyrosine phosphorylation, which leads to Ras activation (12), is
required for ROS production. This conclusion could be questioned,
however, due to the possibility of genistein also being an antioxidant
(23). Seeking independent evidence for the suggested conclusion of the
experiments of Fig. 6, we tried to determine if the ouabain-induced ROS
production required activated Ras. Using procedures that we have used
previously (10), myocytes were transfected with an adenovirus
expressing a dominant negative Ras or a control virus, exposed to
ouabain, and assayed for intracellular ROS. As shown in Fig.
7, ouabain stimulated ROS production in
control myocytes but not in those expressing the dominant negative Ras,
thus indicating that ROS production is Ras-dependent.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of genistein on ouabain-induced ROS
production. Myocytes cultured in the normal
Ca2+-containing medium were preincubated with 100 µM genistein for 30 min, exposed to 100 µM
ouabain for 10 or 30 min, and then assayed for ROS as in Fig. 1. Each
value is the mean ± S.E. of determinations from 30-40 cells in
three independent experiments. At each time point, values are expressed
relative to the control value of one at that time. *p < 0.05.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of the expression of the dominant
negative Ras on the ouabain-induced ROS production in cardiac
myocytes. Myocytes were transduced with either Ras
Asn17 or a control virus for 12 h as indicated under
"Experimental Procedures," then exposed to 100 µM
ouabain and assayed for ROS as in Fig. 1. Each value is the mean ± S.E. of 40-50 determinations in four independent experiments.
|
|
The Sources of the Ouabain-induced ROS--
To begin the
identification of the intracellular origin of ROS generated in response
to ouabain, myocytes were preincubated with different concentrations of
myxothiazol (an inhibitor of ROS generated in mitochondria) or DPI (an
inhibitor of flavoenzymes), then exposed to ouabain, and monitored for
ROS production. In preliminary experiments (not shown) each compound
was found to inhibit the ROS generation, and the maximally effective
concentrations were found to be 0.6 µM myxothiazol and 10 µM DPI. At these optimal concentrations, each compound
blocked a fraction of the ouabain-induced ROS generation, but the
combination of the two caused complete inhibition of the ouabain effect
(Fig. 8). These data, along with those of
Fig. 7, indicate that ouabain-induced and Ras-dependent ROS
originate, at least in part, from the myocyte mitochondria. Evidently,
the ROS-generating pathways that begin at the plasma membrane
Na+/K+-ATPase and are independent of changes in
[Ca2+]i and [Na+]i extend
into the mitochondrial matrix.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of DPI and myxothiazol on the
ouabain-induced ROS production in cardiac myocytes. Myocytes were
pretreated with either 20 µM DPI or 0.6 µM
myxothiazol (MX) or the combination of the two for 15 min
then exposed to 100 µM ouabain. Intracellular ROS were
measured after 30 min of exposure to ouabain as in Fig. 1. Each value,
expressed relative to the control value of one in the absence of
ouabain, is the mean ± S.E. of 40-50 determinations in four
independent experiments. *p < 0.05 in comparison with
control; **p < 0.05 in comparison with ouabain-treated
cells in the absence of DPI and MX.
|
|
Ouabain-induced ROS Generation in Cells Other Than Cardiac
Myocytes--
Because our recent studies (12) showed that the
ouabain-induced increase in protein tyrosine phosphorylation occurred
in cardiac myocytes and several other cell types, it was of interest to
know the cell type specificity of the ouabain-induced ROS generation. In experiments similar to those of Fig. 1, ouabain was found to stimulate ROS generation in A7r5 cells (not shown) and in HeLa cells
(Fig. 9). It is of particular interest
that the effective ouabain concentrations for ROS generation in HeLa
cells are about two orders of magnitude lower than the effective
concentrations in rat cardiac myocytes (Fig. 9 and Ref. 11). This is in
keeping with the established differences in the ouabain sensitivities of the predominant Na+/K+-ATPase isoforms of
these cells (2, 12).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 9.
Dose-dependent effects of ouabain
on the generation of ROS in rat neonatal cardiac myocytes and HeLa
cells. Cells were exposed to the indicated concentrations of
ouabain, and intracellular ROS were measured as in Fig. 1 after 30 min
of exposure. Each value, expressed relative to the control value of one
in the absence of ouabain, is the mean ± S.E. of 40-50
determinations in four independent experiments. *p < 0.05; **p < 0.01.
|
|
In view of the findings of Fig. 9, limited experiments were done to
assess the possible relation of ouabain-induced ROS generation in HeLa
cells to [Ca2+]i and
[Na+]i. As evident from the data of Fig.
10, after 20 min of exposure of the
cells to 0.1 µM ouabain in the normal
Ca2+-containing culture medium, when a large increase in
ROS was noted, there were no significant changes in
[Na+]i and [Ca2+]i. These
findings reinforce the conclusions of the experiments on myocytes by
showing that, with ouabain concentrations that cause partial inhibition
of Na+/K+-ATPase, it is possible to induce ROS
generation without significant increases in
[Ca2+]i or [Na+]i.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 10.
Effects of 0.1 µM ouabain on ROS generation,
[Na+]i and [Ca2+]i in HeLa
cells. Cells cultured in the normal Ca2+-containing
medium were loaded with the appropriate fluorescent probes, exposed to
ouabain for 20 min, and assayed as indicated under "Experimental
Procedures." Each value in the ouabain-treated cell population is
expressed relative to control value in cells not exposed to ouabain.
**p < 0.01. The calculated values of ion
concentrations were: [Na+]i, 12.6 ± 1.5 mM in the control and 13.7 ± 3.9 mM in
the presence of ouabain; [Ca2+]i, 71.7 ± 5.7 nM in the control and 79 ± 9 nM in
the presence of ouabain.
|
|
 |
DISCUSSION |
In our previous studies (7-12) we have shown that the plasma
membrane Na+/K+-ATPase of the cardiac myocyte
acts as a signal transducer by relaying the message of its interaction
with extracellular ouabain to the cell nucleus through several
interrelated pathways. We have also identified portions of these
pathways, including segments that are close to ouabain's interaction
with the Na+/K+-ATPase and involve Src, the
epidermal growth factor receptor, and increased protein tyrosine
phosphorylation. The findings presented here establish that such a
proximal cascade that includes protein tyrosine phosphorylation
followed by the increased generation of intracellular ROS, is
independent of the increases in [Ca2+]i and
[Na+]i that are the expected consequences of
ouabain interaction with the cardiac
Na+/K+-ATPase. The logical conclusion is that
the Na+/K+-ATPase has two distinct roles within
the plasma membrane: One being its classical function as an ion pump,
and the other, as a signal transducer through protein-protein
interactions. This and the other conclusions discussed below are
summarized in Fig. 11.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 11.
Schematic representation of the
Ca2+-independent and the
Ca2+-dependent pathways that are linked to the
cardiac myocyte Na+/K+-ATPase and are activated
in response to ouabain. See "Discussion" and Ref.
12.
|
|
Ouabain-induced Increases in ROS Generation and Protein Tyrosine
Phosphorylation Are Independent of Increases in
[Ca2+]i and
[Na+]i--
When myocytes are placed in a
Ca2+-free medium, there is no ouabain-induced increase in
[Ca2+]i (Figs. 2 and 3, and Table I), but there
are ouabain-induced increases in ROS generation and protein tyrosine
phosphorylation (Figs. 1 and 5), which indicate that these events do
not require the ouabain-induced increase in
[Ca2+]i that is noted when myocytes are in a
Ca2+-containing medium (Fig. 3 and Table I). The
irrelevance of the increase in [Na+]i to the
above ouabain-induced signaling events is also established convincingly
by the findings that, at the ouabain concentration used, with or
without the presence of extracellular Ca2+, changes in
[Na+]i are nonexistent or barely detectable (Fig.
4) and by the lack of effect of monensin on ROS production (Fig. 1). The data on [Na+]i also suggest that a role for
the altered [K+]i is unlikely, because any
ouabain-induced change in [Na+]i is expected to
be accompanied by a smaller ouabain-induced change in
[K+]i. Taken together, the data of Table I and
Figs. 1-5 show that, at the ouabain concentrations used, the induced
pathways leading to increased protein tyrosine phosphorylation and ROS generation are parallel to those leading to a small increase in [Na+]i, which in turn leads to a more prominent
rise in [Ca2+]i through the altered function of
the Na+/Ca2+-exchanger (3-5) as depicted in
Fig. 11.
Two other important aspects of the data of Table I and Figs. 1-5 need
further consideration: 1) The highest ouabain concentration (100 µM) we have used in the experiments on neonatal rat
cardiac myocytes to activate signal cascades does not affect myocyte
viability (7) and causes about 50% inhibition of the
Na+/K+-ATPase activity and the associated
transport function in these cells (7, 24). At first, it may seem odd
that this degree of inhibition of the
Na+/K+-ATPase leads to so little change in the
steady-state [Na+]i as shown in Fig. 4 and also
noted previously in neonatal rat cardiac myocytes (15). This apparent
discrepancy, which has been observed in various cardiac preparations,
is due to the well established reserve capacity of the
Na+/K+-ATPase with respect to the need for the
maintenance of normal Na+ and K+ gradients (4,
5, 18, 19). A number of early studies have demonstrated that more than
about 50% inhibition of cardiac Na+/K+-ATPase
by a cardiac glycoside is required before significant changes in
[Na+]i begin to occur (4, 5, 18). Interestingly, recent studies not involving cardiac glycosides have also indicated the
presence of an excess of Na+/K+-ATPase in the
rat heart by showing that the depression of more than 40% of the
enzyme content is needed before changes in normal Na+ and
K+ gradients are noted (25). The existence of this excess
capacity is also pertinent to the main conclusion of the present work
regarding the dual functions of the
Na+/K+-ATPase (Fig. 11), which suggests that
the signal-transducing function of the enzyme through transient
stimulus-induced protein-protein interactions need not interfere with
the housekeeping function of the enzyme as an ion pump. 2) A number of
studies on the regulation of cardiac hypertrophy have suggested that
contraction per se may be a stimulus for the initiation of
the various gene regulatory signaling pathways (Ref. 17 and references
therein). Our experiments on myocytes in Ca2+-free media
(Figs. 1-5), showing ouabain-induced effects on protein tyrosine
phosphorylation and ROS production in quiescent myocytes, also rule out
contraction, or the altered force of contraction, as the primary
inducer of the signal pathways, at least for those segments that lead
to ROS generation.
Our limited studies on cells other than cardiac myocytes (Figs. 9 and
10, and Ref. 12) suggest that the entire pathway that links
Na+/K+-ATPase to ROS generation (Fig. 11) is
not limited to myocytes. Significantly, the findings on HeLa cells
(Fig. 10) strongly support the conclusions of the myocyte studies by
showing ouabain-induced ROS generation in the absence of increases in
[Ca2+ ]i and [Na+]i. The
ouabain concentration used in these studies (0.1 µM)
inhibits the hydrolytic and transport functions of
Na+/K+-ATPase of the wild-type HeLa cells by
about 40% (26). That [Ca2+]i is not changed by
ouabain (Fig. 10) is in keeping with the known absence of
Na+/Ca2+-exchanger in HeLa cells (27). The
absence of a significant effect of this concentration of ouabain on
[Na+]i (Fig. 10) suggests that HeLa cells, like
myocytes, have an excess of Na+/K+-ATPase in
regard to the need for the maintenance of normal Na+ and
K+ gradients. We know of no previous findings that argue
for or against the existence of such excess in HeLa cells.
The ROS-generating Pathway of Cardiac Myocytes Extends from the
Na+/K+-ATPase to the Mitochondria through
Ras--
The blockade of ouabain-induced ROS production by genistein
(Fig. 6), coupled with the data on dominant negative Ras (Fig. 7),
suggests that the Ras-dependent ROS generation is distal to increases in protein tyrosine phosphorylation and the associated Src
activation that are detailed in the accompanying paper (12). Because in
the absence of extracellular Ca2+ the ouabain-induced ROS
generation persists (Fig. 1), but not the ouabain-induced MAPK
activation (10), we hypothesize two branches beginning at Ras: one
being the Ras/Raf/MEK/MAPK cascade, and the other leading to ROS
generation (Fig. 11). A possible mechanism for the regulation of the
Ras/MAPK cascade by rise in [Ca2+]i is an effect
of a Ca2+/calmodulin-dependent protein kinase
on MEK, suggested in cells other than myocytes (28).
The partial inhibition of ouabain-induced ROS generation by either
myxothiazol or DPI and the complete inhibition by the combination of
the two (Fig. 8) are informative regarding the sources of ROS. Myxothiazol is an inhibitor of the mitochondrial site III electron transport (29, 30), but DPI may block ROS generation through the
mitochondrial complex I or several other cellular sources, including
NAD(P)H oxidase (31). Our data, therefore, implicate the mitochondria
as a source of the ouabain-induced ROS, but do not rule out other
cellular sources. Possible mechanisms for the extension of the
ouabain-induced pathways to the mitochondria include the
Ras/ceramide-mediated stimulation of the mitochondrial ROS generation,
for which there is evidence in cells other than cardiac myocytes (32,
33). Regardless of the mechanistic details, the present findings permit
the important conclusion that signal pathways initiated at
Na+/K+-ATPase through protein-protein
interactions extend to the mitochondria to generate ROS.
Relation between [Ca2+]i and ROS as Second
Messengers--
In cardiac myocytes, and perhaps in all other cells
that also express significant amounts of the plasma membrane
Na+/Ca2+-exchanger, the most prominent early
effect of the gradual inhibition of the
Na+/K+-ATPase on intracellular ions is the rise
in [Ca2+]i rather than changes in
[Na+]i and [K+]i (3-5, 18, 19).
With the partial inhibition of the enzyme, this increased
[Ca2+]i, the source of which is the extracellular
Ca2+, not only regulates contractility, but also the growth
and the gene regulatory effects that are associated with the partial
inhibition of Na+/K+-ATPase, as we have shown
previously (7-10). The present demonstration, that large segments of
the proximal signaling events emanating from
Na+/K+-ATPase do not require the rise in
[Ca2+]i, clearly indicates that this rise is not
an early and all-important second messenger for the gene regulatory
role of the cardiac Na+/K+-ATPase, but that it
cooperates with the increased ROS to regulate distal events and
cross-talk among the pathways (Fig. 11).
 |
FOOTNOTES |
*
This work was supported by Grants HL-36573 and HL-63238
awarded by the NHLBI, National Institutes of Health, United
States Public Health Service, Department of Health and Human Services.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Pharmacology, Medical College of Ohio, 3035 Arlington Ave., Toledo, OH 43614-5804. Tel.: 419-383-4182; Fax: 419-383-2871; E-mail:
mheck@mco.edu.
Published, JBC Papers in Press, June 28, 2000, DOI 10.1074/jbc.M002950200
 |
ABBREVIATIONS |
The abbreviations used are:
[Na+]i, intracellular Na+
concentration;
[Ca2+]i, intracellular free
Ca2+ concentration;
CM-DCF, 5(and
6)-chloromethyl-2',7'-dichlorofluorescein;
CM-DCFH, reduced CM-DCF;
DMEM, Dulbecco's modified Eagle's medium;
DPI, diphenyleneiodonium;
[K+]i, intracellular K+
concentration;
MAPK, mitogen-activated protein kinase;
MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase
kinase;
ROS, reactive oxygen species;
SBFI, sodium binding
benzofuran isophthalate;
SBFI-AM, SBFI acetoxymethyl ester.
 |
REFERENCES |
| 1.
|
Skou, J. C.
(1988)
Methods Enzymol.
156,
1-29
|
| 2.
|
Lingrel, J. B,
and Kuntzweiler, T.
(1994)
J. Biol. Chem.
269,
19659-19662
|
| 3.
|
Eisner, D. A.,
and Smith, T. W.
(1992)
in
The Heart and Cardiovascular System
(Fozzard, H. A.
, Haber, E.
, Jennigs, R. B.
, Katz, A. M.
, and Morgan, H. E., eds), 2nd Ed., Vol. 1
, pp. 863-902, Raven Press, New York
|
| 4.
|
Akera, T.,
and Ng, Y. C.
(1991)
Life Sci.
48,
97-106
|
| 5.
|
Akera, T.,
and Brody, T. M.
(1976)
Life Sci.
18,
135-142
|
| 6.
|
The Digitalis Investigational Group.
(1997)
N. Engl. J. Med.
336,
525-533
|
| 7.
|
Peng, M.,
Huang, L.,
Xie, Z.,
Huang, W.-H.,
and Askari, A.
(1996)
J. Biol. Chem.
271,
10372-10378
|
| 8.
|
Huang, L.,
Li, H.,
and Xie, Z.
(1997)
J. Mol. Cell. Cardiol.
29,
429-437
|
| 9.
|
Huang, L.,
Kometiani, P.,
and Xie, Z.
(1997)
J. Mol. Cell. Cardiol.
29,
3157-3167
|
| 10.
|
Kometiani, P.,
Li, J.,
Gnudi, L.,
Kahn, B. B.,
Askari, A.,
and Xie, Z.
(1998)
J. Biol. Chem.
273,
15249-15256
|
| 11.
|
Xie, Z.,
Kometiani, P.,
Liu, J.,
Li, J.,
Shapiro, J. I.,
and Askari, A.
(1999)
J. Biol. Chem.
274,
19323-19328
|
| 12.
|
Haas, M.,
Askari, A.,
and Xie, Z.
(2000)
J. Biol. Chem.
275,
27832-27837
|
| 13.
|
Liu, J.,
Shapiro, J. I.,
Askari, A.,
and Xie, Z.
(2000)
Biophys. J.
78,
79A
|
| 14.
|
Eigel, B. N.,
and Hadley, R. W.
(1999)
Am. J. Physiol.
277,
H1817-H1822
|
| 15.
|
Yamamoto, K.,
Ikeda, U.,
Seino, Y.,
Tsuruya, Y.,
Oguchi, A.,
Okada, K.,
Ishikawa, S.-E.,
Saito, T.,
Kawakami, K.,
Hara, Y.,
and Shimada, K.
(1993)
J. Clin. Invest.
92,
1889-1895
|
| 16.
|
Simpson, P.
(1985)
Circ. Res.
56,
884-894
|
| 17.
|
Eble, D. M.,
Qi, M.,
Waldschmidt, S.,
Lucchesi, P. A.,
Byron, K. L.,
and Samarel, A. M.
(1998)
Am. J. Physiol.
275,
C1226-C1237
|
| 18.
|
Akera, T.,
Bennett, R. T.,
Olgaard, M. K.,
and Brody, T. M.
(1976)
J. Pharmacol. Exp. Ther.
199,
287-297
|
| 19.
|
Kim, D.,
Barry, W. H.,
and Smith, T. W.
(1984)
J. Pharmacol. Exp. Ther.
231,
326-333
|
| 20.
|
Murphy, E.,
Jacob, R.,
and Lieberman, M.
(1985)
J. Mol. Cell. Cardiol.
17,
221-231
|
| 21.
|
Bhojani, I. H.,
and Chapman, R. A.
(1990)
J. Mol. Cell. Cardiol.
22,
507-522
|
| 22.
|
Jansen, M. A.,
Van Echteld, C. J. A.,
and Ruigrok, T. J. C.
(1998)
Am. J. Physiol.
274,
H846-H852
|
| 23.
|
Ruiz-Larrea, M. B.,
Mohan, A. R.,
Paganga, G.,
Miller, N. J.,
Bolwell, G. P.,
and Rice-Evans, C. A.
(1997)
Free Radic. Res.
26,
63-70
|
| 24.
|
Xie, Z.,
Wang, Y.,
Ganjeizadeh, M.,
McGee, R.,
and Askari, A.
(1989)
Anal. Biochem.
183,
215-219
|
| 25.
|
Alto, L. E.,
Elimban, V.,
Lukas, A.,
and Dhalla, N. S.
(2000)
Mol. Cell. Biochem.
207,
87-94
|
| 26.
|
Price, E. M.,
and Lingrel, J. B.
(1988)
Biochemistry
27,
8400-8408
|
| 27.
|
Furman, I.,
Cook, O.,
Kasir, J.,
Low, W.,
and Rahamimoff, H.
(1995)
J. Biol. Chem.
270,
19120-19127
|
| 28.
|
Egea, J.,
Espinet, C.,
and Comella, J. X.
(1999)
J. Biol. Chem.
274,
75-85
|
| 29.
|
Turrens, J. F.,
Alexandre, A.,
and Lehninger, A. L.
(1985)
Arch. Biochem. Biophys.
237,
408-414
|
| 30.
|
Vanden Hoek, T. L.,
Becker, L. B.,
Shao, Z.,
Li, C.,
and Schumacker, P. T.
(1998)
J. Biol. Chem.
273,
18092-18098
|
| 31.
|
Li, Y.,
and Trush, M. A.
(1998)
Biochem. Biophys. Res. Commun.
253,
295-299
|
| 32.
|
Hannun, Y. A.
(1996)
Science
274,
1855-1859
|
| 33.
|
Lee, A. C.,
Fenster, B. E.,
Ito, H.,
Takeda, K.,
Bae, N. S.,
Hirai, T., Yu, Z. X.,
Ferrans, V. J.,
Howard, B. H.,
and Finkel, T.
(1999)
J. Biol. Chem.
274,
7936-7940
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Wang, A. T. Dennis, P. Trieu, F. Charron, N. Ethier, T. E. Hebert, X. Wan, and E. Ficker
Intracellular Potassium Stabilizes Human Ether-a-go-go-Related Gene Channels for Export from Endoplasmic Reticulum
Mol. Pharmacol.,
April 1, 2009;
75(4):
927 - 937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
Pharmacol. Rev.,
March 1, 2009;
61(1):
9 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Stoilov, C.-H. Lin, R. Damoiseaux, J. Nikolic, and D. L. Black
A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators
PNAS,
August 12, 2008;
105(32):
11218 - 11223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Pierre, Y. Sottejeau, J.-M. Gourbeau, G. Sanchez, A. Shidyak, and G. Blanco
Isoform specificity of Na-K-ATPase-mediated ouabain signaling
Am J Physiol Renal Physiol,
April 1, 2008;
294(4):
F859 - F866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Newman, P. Yang, A. D. Pawlus, and K. I. Block
Cardiac Glycosides as Novel Cancer Therapeutic Agents
Mol. Interv.,
February 1, 2008;
8(1):
36 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Cai, L. Wu, W. Qu, D. Malhotra, Z. Xie, J. I. Shapiro, and J. Liu
Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex
Am J Physiol Cell Physiol,
February 1, 2008;
294(2):
C555 - C563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liu, X. Zhao, S. V. Pierre, and A. Askari
Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes
Am J Physiol Cell Physiol,
November 1, 2007;
293(5):
C1489 - C1497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Khundmiri, V. Amin, J. Henson, J. Lewis, M. Ameen, M. J. Rane, and N. A. Delamere
Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway
Am J Physiol Cell Physiol,
September 1, 2007;
293(3):
C1171 - C1180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Schoner and G. Scheiner-Bobis
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Am J Physiol Cell Physiol,
August 1, 2007;
293(2):
C509 - C536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Kaunitz
Reply to Blaustein et al.
Am J Physiol Renal Physiol,
July 1, 2007;
293(1):
F439 - F439.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Liang, J. Tian, L. Liu, S. Pierre, J. Liu, J. Shapiro, and Z.-J. Xie
Identification of a Pool of Non-pumping Na/K-ATPase
J. Biol. Chem.,
April 6, 2007;
282(14):
10585 - 10593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pasdois, C. L. Quinlan, A. Rissa, L. Tariosse, B. Vinassa, A. D. T. Costa, S. V. Pierre, P. Dos Santos, and K. D. Garlid
Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS
Am J Physiol Heart Circ Physiol,
March 1, 2007;
292(3):
H1470 - H1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Pierre, C. Yang, Z. Yuan, J. Seminerio, C. Mouas, K. D. Garlid, P. Dos-Santos, and Z. Xie
Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts
Cardiovasc Res,
February 1, 2007;
73(3):
488 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Elkareh, D. J. Kennedy, B. Yashaswi, S. Vetteth, A. Shidyak, E. G. R. Kim, S. Smaili, S. M. Periyasamy, I. M. Hariri, L. Fedorova, et al.
Marinobufagenin Stimulates Fibroblast Collagen Production and Causes Fibrosis in Experimental Uremic Cardiomyopathy
Hypertension,
January 1, 2007;
49(1):
215 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Khundmiri, M. A. Metzler, M. Ameen, V. Amin, M. J. Rane, and N. A. Delamere
Ouabain induces cell proliferation through calcium-dependent phosphorylation of Akt (protein kinase B) in opossum kidney proximal tubule cells
Am J Physiol Cell Physiol,
December 1, 2006;
291(6):
C1247 - C1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Kennedy, S. Vetteth, M. Xie, S. M. Periyasamy, Z. Xie, C. Han, V. Basrur, K. Mutgi, V. Fedorov, D. Malhotra, et al.
Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation
Am J Physiol Heart Circ Physiol,
December 1, 2006;
291(6):
H3003 - H3011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Thundathil, M. Anzar, and M. M. Buhr
Na+/K+ATPase as a Signaling Molecule During Bovine Sperm Capacitation
Biol Reprod,
September 1, 2006;
75(3):
308 - 317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Liang, T. Cai, J. Tian, W. Qu, and Z.-J. Xie
Functional Characterization of Src-interacting Na/K-ATPase Using RNA Interference Assay
J. Biol. Chem.,
July 14, 2006;
281(28):
19709 - 19719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Frese, M. Frese-Schaper, A.-C. Andres, D. Miescher, B. Zumkehr, and R. A. Schmid
Cardiac Glycosides Initiate Apo2L/TRAIL-Induced Apoptosis in Non-Small Cell Lung Cancer Cells by Up-regulation of Death Receptors 4 and 5
Cancer Res.,
June 1, 2006;
66(11):
5867 - 5874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Kaunitz
Membrane transport proteins: not just for transport anymore
Am J Physiol Renal Physiol,
May 1, 2006;
290(5):
F995 - F996.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oweis, L. Wu, P. R. Kiela, H. Zhao, D. Malhotra, F. K. Ghishan, Z. Xie, J. I. Shapiro, and J. Liu
Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells
Am J Physiol Renal Physiol,
May 1, 2006;
290(5):
F997 - F1008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ferrari, M. Ferrandi, G. Valentini, and G. Bianchi
Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2006;
290(3):
R529 - R535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Plourde and S. P. Soltoff
Ouabain potentiates the activation of ERK1/2 by carbachol in parotid gland epithelial cells; inhibition of ERK1/2 reduces Na+-K+-ATPase activity
Am J Physiol Cell Physiol,
March 1, 2006;
290(3):
C702 - C710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Kennedy, S. Vetteth, S. M. Periyasamy, M. Kanj, L. Fedorova, S. Khouri, M. B. Kahaleh, Z. Xie, D. Malhotra, N. I. Kolodkin, et al.
Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy
Hypertension,
March 1, 2006;
47(3):
488 - 495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Cantin, G. Bilodeau, C. Ouellet, J. Liao, and J. W. Hanrahan
Oxidant stress suppresses CFTR expression
Am J Physiol Cell Physiol,
January 1, 2006;
290(1):
C262 - C270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tian, T. Cai, Z. Yuan, H. Wang, L. Liu, M. Haas, E. Maksimova, X.-Y. Huang, and Z.-J. Xie
Binding of Src to Na+/K+-ATPase Forms a Functional Signaling Complex
Mol. Biol. Cell,
January 1, 2006;
17(1):
317 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Wasserstrom and G. L. Aistrup
Digitalis: new actions for an old drug
Am J Physiol Heart Circ Physiol,
November 1, 2005;
289(5):
H1781 - H1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yuan, T. Cai, J. Tian, A. V. Ivanov, D. R. Giovannucci, and Z. Xie
Na/K-ATPase Tethers Phospholipase C and IP3 Receptor into a Calcium-regulatory Complex
Mol. Biol. Cell,
September 1, 2005;
16(9):
4034 - 4045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Kaplan
A Moving New Role for the Sodium Pump in Epithelial Cells and Carcinomas
Sci. Signal.,
June 21, 2005;
2005(289):
pe31 - pe31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Scheidenhelm, J. Cresswell, C. A. Haipek, T. P. Fleming, R. W. Mercer, and D. H. Gutmann
Akt-Dependent Cell Size Regulation by the Adhesion Molecule on Glia Occurs Independently of Phosphatidylinositol 3-Kinase and Rheb Signaling
Mol. Cell. Biol.,
April 15, 2005;
25(8):
3151 - 3162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kometiani, L. Liu, and A. Askari
Digitalis-Induced Signaling by Na+/K+-ATPase in Human Breast Cancer Cells
Mol. Pharmacol.,
March 1, 2005;
67(3):
929 - 936.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dong, Q. Li, S.-c. Lyu, A. M. Krensky, and C. Clayberger
A novel apoptosis pathway activated by the carboxyl terminus of p21
Blood,
February 1, 2005;
105(3):
1187 - 1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. Akimova, A. Y. Bagrov, O. D. Lopina, A. V. Kamernitsky, J. Tremblay, P. Hamet, and S. N. Orlov
Cardiotonic Steroids Differentially Affect Intracellular Na+ and [Na+]i/[K+]i-independent Signaling in C7-MDCK Cells
J. Biol. Chem.,
January 7, 2005;
280(1):
832 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y. Xu, E. Takimoto, G. J. Juang, Q. Zhang, H. Rohde, and A. C. Myers
Evidence that the H1-H2 domain of {alpha}1 subunit of (Na++K+)-ATPase participates in the regulation of cardiac contraction
FASEB J,
January 1, 2005;
19(1):
53 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dworschak, D. Breukelmann, and J. D. Hannon
The Impact of Isoflurane During Simulated Ischemia/Reoxygenation on Intracellular Calcium, Contractile Function, and Arrhythmia in Ventricular Myocytes
Anesth. Analg.,
November 1, 2004;
99(5):
1302 - 1307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Barbato, S. Rashid, P. J. Mulrow, J. I. Shapiro, and R. Franco-Saenz
Mechanisms for Aldosterone and Spironolactone-Induced Positive Inotropic Actions in the Rat Heart
Hypertension,
November 1, 2004;
44(5):
751 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ferrandi, I. Molinari, P. Barassi, E. Minotti, G. Bianchi, and P. Ferrari
Organ Hypertrophic Signaling within Caveolae Membrane Subdomains Triggered by Ouabain and Antagonized by PST 2238
J. Biol. Chem.,
August 6, 2004;
279(32):
33306 - 33314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, M. Haas, M. Liang, T. Cai, J. Tian, S. Li, and Z. Xie
Ouabain Assembles Signaling Cascades through the Caveolar Na+/K+-ATPase
J. Biol. Chem.,
April 23, 2004;
279(17):
17250 - 17259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Reich, S. E. Mason, and B. E. Alger
Novel Form of LTD Induced by Transient, Partial Inhibition of the Na,K-Pump in Rat Hippocampal CA1 Cells
J Neurophysiol,
January 1, 2004;
91(1):
239 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Abramowitz, C. Dai, K. K. Hirschi, R. I. Dmitrieva, P. A. Doris, L. Liu, and J. C. Allen
Ouabain- and Marinobufagenin-Induced Proliferation of Human Umbilical Vein Smooth Muscle Cells and a Rat Vascular Smooth Muscle Cell Line, A7r5
Circulation,
December 16, 2003;
108(24):
3048 - 3053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu and J. I. Shapiro
Endocytosis and Signal Transduction: Basic Science Update
Biol Res Nurs,
October 1, 2003;
5(2):
117 - 128.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xie and T. Cai
Na+-K+-ATPase-Mediated Signal Transduction: From Protein Interaction to Cellular Function
Mol. Interv.,
May 1, 2003;
3(3):
157 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Baudouin-Legros, F. Brouillard, D. Tondelier, A. Hinzpeter, and A. Edelman
Effect of ouabain on CFTR gene expression in human Calu-3 cells
Am J Physiol Cell Physiol,
March 1, 2003;
284(3):
C620 - C626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kennedy, E. Omran, S. M. Periyasamy, J. Nadoor, A. Priyadarshi, J. C. Willey, D. Malhotra, Z. Xie, and J. I. Shapiro
Effect of Chronic Renal Failure on Cardiac Contractile Function, Calcium Cycling, and Gene Expression of Proteins Important for Calcium Homeostasis in the Rat
J. Am. Soc. Nephrol.,
January 1, 2003;
14(1):
90 - 97.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishio, S. W. Ruch, and J. A. Wasserstrom
Positive inotropic effects of ouabain in isolated cat ventricular myocytes in sodium-free conditions
Am J Physiol Heart Circ Physiol,
November 1, 2002;
283(5):
H2045 - H2053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Taurin, N. O Dulin, D. Pchejetski, R. Grygorczyk, J. Tremblay, P. Hamet, and S. N Orlov
c-Fos expression in ouabain-treated vascular smooth muscle cells from rat aorta: evidence for an intracellular-sodium-mediated, calcium-independent mechanism
J. Physiol.,
September 15, 2002;
543(3):
835 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Dmitrieva and P. A. Doris
Cardiotonic Steroids: Potential Endogenous Sodium Pump Ligands with Diverse Function
Experimental Biology and Medicine,
September 1, 2002;
227(8):
561 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kajikawa, S. Fujimoto, Y. Tsuura, E. Mukai, T. Takeda, Y. Hamamoto, M. Takehiro, J. Fujita, Y. Yamada, and Y. Seino
Ouabain Suppresses Glucose-Induced Mitochondrial ATP Production and Insulin Release by Generating Reactive Oxygen Species in Pancreatic Islets
Diabetes,
August 1, 2002;
51(8):
2522 - 2529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Haas, H. Wang, J. Tian, and Z. Xie
Src-mediated Inter-receptor Cross-talk between the Na+/K+-ATPase and the Epidermal Growth Factor Receptor Relays the Signal from Ouabain to Mitogen-activated Protein Kinases
J. Biol. Chem.,
May 17, 2002;
277(21):
18694 - 18702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Rajasekaran, L. G. Palmer, S. Y. Moon, A. Peralta Soler, G. L. Apodaca, J. F. Harper, Y. Zheng, and A. K. Rajasekaran
Na,K-ATPase Activity Is Required for Formation of Tight Junctions, Desmosomes, and Induction of Polarity in Epithelial Cells
Mol. Biol. Cell,
December 1, 2001;
12(12):
3717 - 3732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Aydemir-Koksoy, J. Abramowitz, and J. C. Allen
Ouabain-induced Signaling and Vascular Smooth Muscle Cell Proliferation
J. Biol. Chem.,
November 30, 2001;
276(49):
46605 - 46611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mohammadi, P. Kometiani, Z. Xie, and A. Askari
Role of Protein Kinase C in the Signal Pathways That Link Na+/K+-ATPase to ERK1/2
J. Biol. Chem.,
November 2, 2001;
276(45):
42050 - 42056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tian, X. Gong, and Z. Xie
Signal-transducing function of Na+-K+-ATPase is essential for ouabain's effect on [Ca2+]i in rat cardiac myocytes
Am J Physiol Heart Circ Physiol,
November 1, 2001;
281(5):
H1899 - H1907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Manzerra, M. M. Behrens, L. M. T. Canzoniero, X. Q. Wang, V. Heidinger, T. Ichinose, S. P. Yu, and D. W. Choi
Zinc induces a Src family kinase-mediated up-regulation of NMDA receptor activity and excitotoxicity
PNAS,
September 25, 2001;
98(20):
11055 - 11061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Haas, A. Askari, and Z. Xie
Involvement of Src and Epidermal Growth Factor Receptor in the Signal-transducing Function of Na+/K+-ATPase
J. Biol. Chem.,
September 1, 2000;
275(36):
27832 - 27837.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|